National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Genetics of Colorectal Cancer (PDQ®)
Health Professional Version   Last Modified: 12/19/2008
Table 7C. Summary of Studies Evaluating Interest in or Intention to Have Genetic Counseling and Testing for Familial Adenomatous Polyposis (FAP)a

Study Population   Nb  Interest or Intention in GC or GTc 
FAP-affected individuals [16] 25 60% prenatal GT interest; 18% would consider aborting fetus if mutation was found
FAP-affected individuals [17] 62 65% prenatal GT interest; 24% would consider aborting fetus if mutation was found; 94% GT interest at birth

GC = genetic counseling; GT = genetic testing.
aBoth studies used a cross-sectional design and were conducted in the United Kingdom.[16,17]
bIndicates number of participants older than 18 y, unless otherwise specified.
cType of genetic test not specified.

References

  1. Burn J, Chapman P, Delhanty J, et al.: The UK Northern region genetic register for familial adenomatous polyposis coli: use of age of onset, congenital hypertrophy of the retinal pigment epithelium, and DNA markers in risk calculations. J Med Genet 28 (5): 289-96, 1991.  [PUBMED Abstract]

  2. Whitelaw S, Northover JM, Hodgson SV: Attitudes to predictive DNA testing in familial adenomatous polyposis. J Med Genet 33 (7): 540-3, 1996.  [PUBMED Abstract]


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov